We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Presents Virtual Showcase of Laboratory Solutions at EUROMEDLAB 2022

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022
Print article
Image: Beckman Coulter\'s immersive 3D virtual product showcase (Photo courtesy of Beckman Coulter)
Image: Beckman Coulter\'s immersive 3D virtual product showcase (Photo courtesy of Beckman Coulter)

To make up for its physical absence at the hybrid EUROMEDLAB 2022 event, Beckman Coulter, Inc. (Brea, CA, USA) presented its instruments and workflow solutions for laboratories of all sizes through its immersive, 3D virtual product showcase.

Beckman Coulter’s virtual showcase displayed its line of instruments and automation specially designed to elevate the performance of low, medium, and high-volume laboratories. This included the DxA 5000 Fit workflow automation system that fundamentally improves lab workflow by making intelligent automation accessible to fit the needs of small- and mid-sized labs. The DxA 5000 Fit drives speed and accuracy, all while maintaining a small footprint. It eliminates up to 80% of the manual steps associated with processing a patient sample, allowing labs to keep their focus on what matters most: patient care. The DxA 5000 Fit can be designed in unique configurations that allow the automation system to fit any lab’s needs. With flexible line customization and a compact footprint, the DxA 5000 Fit can accommodate different workloads and footprints while optimizing laboratory space.

Beckman Coulter’s virtual showcase also included the DxU Iris Workcell fully automated system that streamlines urinalysis workflow and reduces manual reviews to 4%. The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software to enable laboratories to deliver standardized results using artificial intelligence (AI). This industry-leading technology isolates, identifies, and characterizes urine particles to provide immediate, accurate, and reproducible results verified directly on the screen.

Also on display at Beckman Coulter’s virtual showcase was the DxH 560 AL hematology analyzer that helps save time and resources, eliminate manual intervention and deliver high-quality results, even for difficult-draw patient groups. The multi-tube, compact hematology analyzer allows labs to load and go up to 50 samples with on-the-fly continuous loading more than twice the capacity compared to the closest competitor. Among others, Beckman Coulter provided a glimpse of its MicroScan microbiology solutions in 3D that provide first-time accuracy with direct MIC for trusted detection of emerging and critical antimicrobial resistance. The company displayed its microbiology panels, systems and analyzers that can improve workflow by automating and standardizing all core aspects of specimen processing for even the most challenging samples. Viewers experienced how patient care can be enhanced with direct MIC methods to provide trusted detection of emerging and critical antimicrobial resistance, while organizing data and managing results with the company’s easy-to-use LabPro software suite.

Related Links:
Beckman Coulter, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.